Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA genuine allergy to tirzepatide is rare, but it does happen — and knowing the difference between an allergic reaction and an ordinary side effect matters. True tirzepatide allergy involves an immune response to the medicine itself, producing symptoms that can range from a localised skin reaction to, in uncommon cases, a serious systemic reaction requiring urgent medical attention. Mounjaro is a prescription-only medicine; your prescriber assesses your suitability before treatment begins, and any signs of allergy during treatment should be discussed with a clinician promptly.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people starting tirzepatide experience some degree of nausea, stomach upset or fatigue in the first few weeks. These are well-documented effects of the medicine working on gut-hormone receptors, and they typically settle as your body adjusts. A tirzepatide allergy is something different: it involves the immune system treating the medicine as a threat and mounting a response against it.
Injection-site reactions (localised redness, a small lump, mild itching where the needle went in) are also relatively common and are not the same as a systemic allergy. They usually fade within a day or two and can often be reduced by rotating injection sites across the abdomen, thigh and upper arm. Keeping the pen in the fridge door and letting it come closer to room temperature for a few minutes before injecting can also make the injection more comfortable, though always follow the storage instructions in the Patient Information Leaflet.
A broader allergic response tends to appear across the body: widespread hives or a rash beyond the injection site, swelling of the face, lips or throat, sudden difficulty swallowing, a drop in blood pressure, or dizziness and collapse. These signs point to an immune reaction rather than a routine side effect. The NHS tirzepatide medicines page lists the full side-effect profile and notes the distinction between local reactions and signs of serious allergy. For a broader look at what the medicine can cause during treatment, our overview of tirzepatide side effects covers the full spectrum.
Serious allergic reactions (anaphylaxis) are rare with tirzepatide, but they are listed in the medicine's Summary of Product Characteristics as a risk to be aware of. The signs to take seriously include sudden swelling of the tongue or throat, a spreading rash that appears quickly, wheezing or difficulty breathing, a racing heart, or feeling faint without another obvious cause.
If you or someone near you experiences these symptoms after a tirzepatide injection, call 999 immediately. Do not wait to see if it settles, and do not take the next scheduled dose. This is true even if earlier injections caused no reaction: immune responses can develop after repeated exposures, so a previous tolerance does not rule out an allergy developing later.
Milder but still concerning signs (persistent widespread hives, significant facial swelling, or an itchy rash that spreads beyond the injection site) warrant a call to 111 or your prescriber the same day rather than waiting for a scheduled appointment. You can also report a suspected reaction directly through the MHRA Yellow Card scheme, which collects this safety information for ongoing monitoring of all licensed medicines including tirzepatide. Our page on tirzepatide allergy symptoms goes into more detail on what each presentation may indicate.
A confirmed systemic allergy to tirzepatide generally means the medicine cannot safely be continued. Your prescriber will review what happened, assess the severity, and decide whether re-challenging the medicine is appropriate, in most cases of true allergy, it is not.
This does not mean weight-management treatment ends there. Semaglutide, the active ingredient in Wegovy, works through a different mechanism (a GLP-1 receptor agonist rather than tirzepatide's dual GIP and GLP-1 approach) and has a different molecular structure. An allergy to tirzepatide does not automatically mean you will react to semaglutide, although that is a clinical decision your prescriber needs to make carefully, not something to self-determine. Our page on weight-loss treatment options explains the licensed alternatives available in the UK. For questions about the Mounjaro brand specifically, our page on being allergic to Mounjaro looks at the same topic from a brand-name angle, which may be useful if you've been prescribed it under that name.
The cost context of switching treatment is sometimes a concern for people in this situation. Our Mounjaro pricing and access page gives an honest account of what private treatment involves financially, which may help if you need to reassess your options with your prescriber.
Clear, specific information helps your prescriber distinguish a true allergic reaction from a side effect and choose the right next step. Try to note when the reaction started relative to the injection (within minutes, within hours, or a day or two later), where on the body it appeared, what it looked like, how long it lasted, and whether it resolved on its own or needed antihistamines or medical treatment.
Also flag any history of allergies to other medicines, vaccines, or injectable products, including allergies to excipients (the non-active ingredients in a formulation). Tirzepatide's excipients include sodium phosphate buffer, mannitol, polysorbate 80 and water for injections; the full list is in the SmPC on the Electronic Medicines Compendium (eMC), which your prescriber may check for cross-reactive substances. A question our prescribers hear regularly is whether a mild skin reaction means stopping immediately, and if you want to understand the full picture before that conversation, our guide to allergy to Mounjaro sets out what to expect and what to ask. The honest answer is that it depends on the nature and extent of the reaction, which is exactly why a same-day clinical conversation matters more than guessing.
At nume, a real prescriber reviews every consultation and every reported concern. If something has happened during your treatment that worries you, our aftercare team is available seven days a week and can connect you with clinical support promptly. For a broader picture of the Mounjaro experience, our Mounjaro overview covers how the medicine works and what treatment typically involves.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.